Skip to main content
Caplight Logo









Mikrobiomik

Mikrobiomik

Private
DerioHealthcare & Life Scienceshttps://mikrobiomik.net/

Last Round

Crowdfunding

Sep 30, 2025

Est. Valuation

$16.68M

Total Funding Raised

$1.89M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Mikrobiomik is a biotechnology company that researches, develops, and produces biological medicines based on the intestinal microbiota.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Precision Medicine

Business Model

B2G

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

microbiome therapyhuman microbiomeoral microbiota therapyCDI treatmentgut microbiomefecal microbiota transplantpoop pilllive biotherapeutic productClostridioides difficile infectionbiological medicinesdrug developmentGMP manufacturingSoHO Regulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Mikrobiomik Comparables

Compare Mikrobiomik with similar companies based on industry and business-model similarity.

Mikrobiomik comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Human Biome S.A.
84%
EnteroBiotix
81%
Vedanta Biosciences
80%

Mikrobiomik Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingSep 30, 2025
VC RoundMar 1, 2025
Series AApr 29, 2024
VC RoundMar 1, 2024
VC RoundSep 25, 2023
VC Round
Mar 11, 2022

Mikrobiomik Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 43% MoM, reaching 3.9K.

  • Jan 27, 2026

    Monthly visitors increased 36% MoM, reaching 5.3K.

Mikrobiomik Filings

Explore SEC and related filing metadata, where available.

Mikrobiomik filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Mikrobiomik's valuation, stock price, and market status.

Is Mikrobiomik a public or private company?

Mikrobiomik is a private company.

What is the current stock price of Mikrobiomik?

Mikrobiomik is a private company with no public stock price. No recent secondary market data is available.

How much is Mikrobiomik worth (valuation)?

Mikrobiomik's valuation is estimated at $16.7M based on funding round data.

Can I buy Mikrobiomik stock?

Mikrobiomik shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Mikrobiomik's last funding round?

Mikrobiomik's most recent funding round was Crowdfunding on September 30, 2025.

Who are the main investors in Mikrobiomik?

Key investors in Mikrobiomik include Seed Capital Bizkaia, Orza.

Will Mikrobiomik IPO soon?

No public IPO plans have been announced for Mikrobiomik.

How can I track Mikrobiomik secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Mikrobiomik's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDerio
Employee Range18
Year Founded2018
Last FundingSep 30, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?